Bausch + Lomb launched a preservative-free form of Lumify redness-reducing eye drops in the U.S., according to a press ...

The FDA cleared an investigational new drug application for a phase 2 trial of GRF312 ophthalmic solution, an immunoglobulin ...

AvKare did not specify what issues had been identified. The five recalled products include lubricant eye drops and eye gels, which consumers should immediately cease using, AvKare warned.

LUMIFY eye drops were initially introduced by Bausch + Lomb in 2018 and remain the only OTC redness relievers that ...

Tens of thousands of cases of eye drops have been recalled by BRS Analytical Services. The recall was initiated on April 23, but the Food and Drug Administration listed it as a Class II on May 6, ...

If you suffer from dry or itchy eyes, listen up: more than 75,000 cases of eye drop solution were voluntarily recalled nationwide by BRS Analytical Service, a pharmaceutical testing lab ...

Nearly 76,000 cases of eye care products – including eye drops sold nationwide – have been recalled by their manufacturer. BRS Analytical Service LLC has voluntarily recalled the items ...

In all, 75,795 cases have been recalled, or 1.8 million cartons of eye drops. The reason for the recall is the potential lack of sterility and cGMP deviations. The term cGMP stands for Current ...

Eye drops and artificial tears must be sterile because the eyes are extremely sensitive and vulnerable to infections. Contaminated eye products can cause serious eye infections, irritation ...

Eye care products, including artificial tears and drops, are being recalled by their distributor. The recall responds to deviations from good manufacturing practices discovered during a U.S. Food ...